Millennium Management increased its stake in AbbVie and purchased shares of SpaceX stock on September 12, 2026.
3 reports, 1 independent
Updated Sep 12
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Millennium Management increased its stake in AbbVie and purchased shares of SpaceX stock on September 12, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Millennium Management
alternative investment management firm
-
SpaceX
American private aerospace company
Related events
- Multiple financial firms acquired new stakes in SpaceX shares and reaffirmed buy ratings on October 13, 2026.
- Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in SpaceX stock by 16.8%.
- Ark Invest purchased over $25 million of Rocket Lab stock while the company continues to compete with SpaceX in launch services.
- SpaceX listed shares on Nasdaq and reached a $2 trillion valuation, while the company explores ambitious plans like AI data centers in space and profitable Starlink operations.
- AbbVie, MIT, Amgen, and John Doerr are Limited Partners in Yosemite's fund.